In cases of COPD and severe asthma, decreased Histone deacetylase 2 (HDAC2) impairs the effectiveness of corticosteroids, which antioxidants like heparin could potentially ameliorate. This evidence concerns the gene HDAC2 and chronic obstructive pulmonary disease.